How Does HIPAA Impact Research and Development in Catalysis?
Researchers working on catalytic processes in drug development must handle Protected Health Information (PHI) with care. HIPAA sets strict guidelines on how PHI should be treated, ensuring that any data used in research is de-identified unless explicit patient consent is obtained. This impacts how data is collected, stored, and shared within research teams.
